GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

NCT00381303 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV
Infectious

Interventions

DRUG: darunavir
DRUG: ritonavir

Sponsor

Tibotec, Inc

Collaborators

[object Object]